Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Tekes.
Twitter and News
Advanced viral nanovaccine for cancer immunotherapy
Researchers at the University of Helsinki have discovered a novel system to generate an artificially enveloped oncolytic adenovirus to direct...
As an expert in Oncolytic Virotherapy Professor Cerullo is ranked no: 13 in the world.
The founder of Expertscape believes that no one is an expert at anything unless they are investigating the leading edge of knowledge and are...
Members of the ImmunoViroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.
One of my main priorities is promoting science to non-scientific audience and I believe that it has never been a better time then now to do...